RESUMEN
Systemic dosing of adeno-associated viral (AAV) vectors poses potential risk of adverse side effects including complement activation triggered by anti-capsid immunity. Due to the multifactorial nature of toxicities observed in this setting, a wide spectrum of immune modulatory regimens are being investigated in the clinic. Here, we discover an IgM cleaving enzyme (IceM) that degrades human IgM, a key trigger in the anti-AAV immune cascade. We then engineer a fusion enzyme (IceMG) with dual proteolytic activity against human IgM and IgG. IceMG cleaves B cell surface antigen receptors and inactivates phospholipase gamma signaling in vitro. Importantly, IceMG is more effective at inhibiting complement activation compared with an IgG cleaving enzyme alone. Upon IV dosing, IceMG rapidly and reversibly clears circulating IgM and IgG in macaques. Antisera from these animals treated with IceMG shows decreased ability to neutralize AAV and activate complement. Consistently, pre-conditioning with IceMG restores AAV transduction in mice passively immunized with human antisera. Thus, IgM cleaving enzymes show promise in simultaneously addressing multiple aspects of anti-AAV immunity mediated by B cells, circulating antibodies and complement. These studies have implications for improving safety of AAV gene therapies and possibly broader applications including organ transplantation and autoimmune diseases.
Asunto(s)
Activación de Complemento , Dependovirus , Vectores Genéticos , Inmunoglobulina G , Inmunoglobulina M , Dependovirus/genética , Dependovirus/inmunología , Animales , Inmunoglobulina M/inmunología , Humanos , Inmunoglobulina G/inmunología , Ratones , Vectores Genéticos/genética , Vectores Genéticos/administración & dosificación , Anticuerpos Neutralizantes/inmunología , Transducción Genética , Técnicas de Transferencia de Gen , Anticuerpos Antivirales/inmunología , Proteolisis , Terapia Genética/métodos , Ingeniería de ProteínasRESUMEN
Adeno-associated viruses (AAVs) are small, helper-dependent, single-stranded DNA viruses that exploit a broad spectrum of host factors for cell entry. During the course of infection, several AAV serotypes have been shown to transit through the trans-Golgi network within the host cell. In the current study, we investigated whether the Golgi-localized, calcium-dependent protease furin influences AAV transduction. While CRISPR/Cas9-mediated knockout (KO) of the Furin gene minimally affected the transduction efficiency of most recombinant AAV serotypes tested, we observed a striking increase in transgene expression (~2 log orders) for the African green monkey isolate AAV4. Interrogation of different steps in the infectious pathway revealed that AAV4 binding, uptake, and transcript levels are increased in furin KO cells, but postentry steps such as uncoating or nuclear entry remain unaffected. Recombinant furin does not cleave AAV4 capsid proteins nor alter cellular expression levels of essential factors such as AAVR or GPR108. Interestingly, fluorescent lectin screening revealed a marked increase in 2,3-O-linked sialoglycan staining on the surface and perinuclear space of furin KO cells. The essential nature of increased sialoglycan expression in furin KO cells in enhancing AAV4 transduction was further corroborated by (i) increased transduction by the closely related isolates AAVrh.32.33 and sea lion AAV and (ii) selective blockade or removal of cellular 2,3-O-linked sialoglycans by specific lectins or neuraminidase, respectively. Based on the overall findings, we postulate that furin likely plays a key role in regulating expression of cellular sialoglycans, which in turn can influence permissivity to AAVs and possibly other viruses. IMPORTANCE Adeno-associated viruses (AAVs) are a proven recombinant vector platform for gene therapy and have demonstrated success in the clinic. Continuing to improve our knowledge of AAV-host cell interactions is critical for improving the safety and efficacy. The current study dissects the interplay between furin, a common intracellular protease, and certain cell surface sialoglycans that serve as viral attachment factors for cell entry. Based on the findings, we postulate that differential expression of furin in host cells and tissues is likely to influence gene expression by certain recombinant AAV serotypes.
Asunto(s)
Dependovirus , Internalización del Virus , Animales , Chlorocebus aethiops , Dependovirus/metabolismo , Furina/genética , Furina/metabolismo , Vectores Genéticos , Proteínas de la Cápside/genética , Transducción GenéticaRESUMEN
O-linked ß-N-acetylglucosamine (O-GlcNAc) is a dynamic form of intracellular glycosylation common in animals, plants and other organisms. O-GlcNAcylation is essential in mammalian cells and is dysregulated in myriad human diseases, such as cancer, neurodegeneration and metabolic syndrome. Despite this pathophysiological significance, key aspects of O-GlcNAc signaling remain incompletely understood, including its impact on fundamental cell biological processes. Here, we investigate the role of O-GlcNAcylation in the coat protein II complex (COPII), a system universally conserved in eukaryotes that mediates anterograde vesicle trafficking from the endoplasmic reticulum. We identify new O-GlcNAcylation sites on Sec24C, Sec24D and Sec31A, core components of the COPII system, and provide evidence for potential nutrient-sensitive pathway regulation through site-specific glycosylation. Our work suggests a new connection between metabolism and trafficking through the conduit of COPII protein O-GlcNAcylation.
Asunto(s)
Acetilglucosamina , Retículo Endoplásmico , Acetilglucosamina/metabolismo , Animales , Retículo Endoplásmico/metabolismo , Glicosilación , Mamíferos/metabolismo , N-Acetilglucosaminiltransferasas/metabolismo , Nutrientes , Procesamiento Proteico-Postraduccional , Transducción de SeñalRESUMEN
O-GlcNAcylation is an essential, nutrient-sensitive post-translational modification, but its biochemical and phenotypic effects remain incompletely understood. To address this question, we investigated the global transcriptional response to perturbations in O-GlcNAcylation. Unexpectedly, many transcriptional effects of O-GlcNAc transferase (OGT) inhibition were due to the activation of NRF2, the master regulator of redox stress tolerance. Moreover, we found that a signature of low OGT activity strongly correlates with NRF2 activation in multiple tumor expression datasets. Guided by this information, we identified KEAP1 (also known as KLHL19), the primary negative regulator of NRF2, as a direct substrate of OGT We show that O-GlcNAcylation of KEAP1 at serine 104 is required for the efficient ubiquitination and degradation of NRF2. Interestingly, O-GlcNAc levels and NRF2 activation co-vary in response to glucose fluctuations, indicating that KEAP1 O-GlcNAcylation links nutrient sensing to downstream stress resistance. Our results reveal a novel regulatory connection between nutrient-sensitive glycosylation and NRF2 signaling and provide a blueprint for future approaches to discover functionally important O-GlcNAcylation events on other KLHL family proteins in various experimental and disease contexts.
Asunto(s)
Regulación de la Expresión Génica , Glicosilación , Proteína 1 Asociada A ECH Tipo Kelch/metabolismo , N-Acetilglucosaminiltransferasas/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Transducción de Señal , Estrés Fisiológico , Línea Celular , Alimentos , Perfilación de la Expresión Génica , Humanos , Oxidación-ReducciónRESUMEN
O-GlcNAc is an intracellular posttranslational modification that governs myriad cell biological processes and is dysregulated in human diseases. Despite this broad pathophysiological significance, the biochemical effects of most O-GlcNAcylation events remain uncharacterized. One prevalent hypothesis is that O-GlcNAc moieties may be recognized by "reader" proteins to effect downstream signaling. However, no general O-GlcNAc readers have been identified, leaving a considerable gap in the field. To elucidate O-GlcNAc signaling mechanisms, we devised a biochemical screen for candidate O-GlcNAc reader proteins. We identified several human proteins, including 14-3-3 isoforms, that bind O-GlcNAc directly and selectively. We demonstrate that 14-3-3 proteins bind O-GlcNAc moieties in human cells, and we present the structures of 14-3-3ß/α and γ bound to glycopeptides, providing biophysical insights into O-GlcNAc-mediated protein-protein interactions. Because 14-3-3 proteins also bind to phospho-serine and phospho-threonine, they may integrate information from O-GlcNAc and O-phosphate signaling pathways to regulate numerous physiological functions.
Asunto(s)
Proteínas 14-3-3/química , Proteínas 14-3-3/metabolismo , Acetilglucosamina/química , Acetilglucosamina/metabolismo , Células HEK293 , Humanos , Espectrometría de Masas , Modelos Moleculares , Fosfopiruvato Hidratasa/química , Fosfopiruvato Hidratasa/metabolismo , ProteómicaRESUMEN
The COPII coat complex, which mediates secretory cargo trafficking from the endoplasmic reticulum, is a key control point for subcellular protein targeting. Because misdirected proteins cannot function, protein sorting by COPII is critical for establishing and maintaining normal cell and tissue homeostasis. Indeed, mutations in COPII genes cause a range of human pathologies, including cranio-lenticulo-sutural dysplasia (CLSD), which is characterized by collagen trafficking defects, craniofacial abnormalities, and skeletal dysmorphology. Detailed knowledge of the COPII pathway is required to understand its role in normal cell physiology and to devise new treatments for disorders in which it is disrupted. However, little is known about how vertebrates dynamically regulate COPII activity in response to developmental, metabolic, or pathological cues. Several COPII proteins are modified by O-linked ß-N-acetylglucosamine (O-GlcNAc), a dynamic form of intracellular protein glycosylation, but the biochemical and functional effects of these modifications remain unclear. Here, we use a combination of chemical, biochemical, cellular, and genetic approaches to demonstrate that site-specific O-GlcNAcylation of COPII proteins mediates their protein-protein interactions and modulates cargo secretion. In particular, we show that individual O-GlcNAcylation sites of SEC23A, an essential COPII component, are required for its function in human cells and vertebrate development, because mutation of these sites impairs SEC23A-dependent in vivo collagen trafficking and skeletogenesis in a zebrafish model of CLSD. Our results indicate that O-GlcNAc is a conserved and critical regulatory modification in the vertebrate COPII-dependent trafficking pathway.
Asunto(s)
Acetilglucosamina/metabolismo , Vesículas Cubiertas por Proteínas de Revestimiento/metabolismo , Proteínas de Transporte Vesicular/metabolismo , Acilación , Animales , Línea Celular , Colágeno/metabolismo , Anomalías Craneofaciales/metabolismo , Modelos Animales de Enfermedad , Glicosilación , Humanos , Orgánulos/metabolismo , Conformación Proteica , Procesamiento Proteico-Postraduccional , Transporte de Proteínas , Vertebrados , Proteínas de Transporte Vesicular/química , Proteínas de Transporte Vesicular/genética , Pez CebraRESUMEN
Trehalose is a disaccharide produced by many organisms to better enable them to survive environmental stresses, including heat, cold, desiccation, and reactive oxygen species. Mammalian cells do not naturally biosynthesize trehalose; however, when introduced into mammalian cells, trehalose provides protection from damage associated with freezing and drying. One of the major difficulties in using trehalose as a cellular protectant for mammalian cells is the delivery of this disaccharide into the intracellular environment; mammalian cell membranes are impermeable to the hydrophilic sugar trehalose. A panel of cell-permeable trehalose analogues, in which the hydrophilic hydroxyl groups of trehalose are masked as esters, have been synthesized and the ability of these analogues to load trehalose into mammalian cells has been evaluated. Two of these analogues deliver millimolar concentrations of free trehalose into a variety of mammalian cells. Critically, Jurkat cells incubated with these analogues show improved survival after heat shock, relative to untreated Jurkat cells. The method reported herein thus paves the way for the use of esterified analogues of trehalose as a facile means to deliver high concentrations of trehalose into mammalian cells for use as a cellular protectant.
Asunto(s)
Trehalosa/análogos & derivados , Animales , Supervivencia Celular/efectos de los fármacos , Esterificación , Células HeLa , Humanos , Células Jurkat , Ratones , Células 3T3 NIH , Temperatura , Trehalosa/metabolismo , Trehalosa/farmacologíaRESUMEN
Recent studies have shown that molecular phylogenies of the choanoflagellates (Class Choanoflagellatea) are in disagreement with their traditional taxonomy, based on morphology, and that Choanoflagellatea requires considerable taxonomic revision. Furthermore, phylogenies suggest that the morphological and ecological evolution of the group is more complex than has previously been recognized. Here we address the taxonomy of the major choanoflagellate order Craspedida, by erecting four new genera. The new genera are shown to be morphologically, ecologically and phylogenetically distinct from other choanoflagellate taxa. Furthermore, we name five novel craspedid species, as well as formally describe ten species that have been shown to be either misidentified or require taxonomic revision. Our revised phylogeny, including 18 new species and sequence data for two additional genes, provides insights into the morphological and ecological evolution of the choanoflagellates. We examine the distribution within choanoflagellates of these two additional genes, EF-1A and EFL, closely related translation GTPases which are required for protein synthesis. Mapping the presence and absence of these genes onto the phylogeny highlights multiple events of gene loss within the choanoflagellates.
Asunto(s)
Coanoflagelados/genética , Genes Protozoarios , Filogenia , Animales , Coanoflagelados/clasificación , ADN Ribosómico/genética , Evolución Molecular , Agua Dulce , Funciones de Verosimilitud , Agua de Mar , Especificidad de la EspecieRESUMEN
Human papillomavirus (HPV) can infect the tonsillar tissues of the oropharynx and is associated with oropharyngeal squamous cell carcinoma. This article provides an overview to guide primary care providers in screening patients for oropharyngeal cancer and making appropriate referrals. The article also reviews available HPV vaccines and immunization adherence rates.
Asunto(s)
Carcinoma de Células Escamosas/virología , Detección Precoz del Cáncer/métodos , Neoplasias de Cabeza y Cuello/virología , Neoplasias Orofaríngeas/virología , Papillomaviridae , Carcinoma de Células Escamosas/diagnóstico , Femenino , Neoplasias de Cabeza y Cuello/diagnóstico , Humanos , Masculino , Neoplasias Orofaríngeas/diagnóstico , Vacunas contra Papillomavirus/administración & dosificación , Factores de Riesgo , Carcinoma de Células Escamosas de Cabeza y CuelloRESUMEN
We report an investigation of the influence of reversible self-assembly of amphiphilic redox-mediators on interfacial charge transfer at chemically functionalized electrodes. Specifically, we employed (11-ferrocenylundecyl)-trimethylammonium bromide (FTMA) as a model self-assembling redox mediator and alkanethiol-modified gold films as hydrophobic electrodes. By performing cyclic voltammetry (CV, 10 mV/s) in aqueous solutions containing FTMA above its critical micellar concentration (CMC), we measured anodic (Ia) and cathodic (Ic) peak current densities of 18 ± 3 and 1.1 ± 0.1 µA/cm(2), respectively, revealing substantial current rectification (Ia/Ic= 17) at the hydrophobic electrodes. In contrast, hydroxymethyl ferrocene (a non-self-assembling redox mediator) at hydrophobic electrodes and FTMA at bare gold electrodes, yielded relatively low levels of rectification (Ia/Ic= 1.7 and 2.3, respectively). Scan-rate-dependent measurements revealed Ia of FTMA to arise largely from the diffusion of FTMA from bulk solution to the hydrophobic electrode whereas Ic was dominated by adsorbed FTMA, leading to the proposal that current rectification observed with FTMA is mediated by interfacial assemblies of reduced FTMA that block access of oxidized FTMA to the hydrophobic electrode. Support for this proposal was obtained by using atomic force microscopy and quartz crystal microbalance measurements to confirm the existence of interfacial assemblies of reduced FTMA (1.56 ± 0.2 molecules/nm(2)). Additional characterization of a mixed surfactant system containing FTMA and dodecyltrimethylammonium bromide (DTAB) revealed that interfacial assemblies of DTAB also block access of oxidized FTMA to hydrophobic electrodes; this system exhibited Ia/Ic > 80. These results and others reported in this paper suggest that current rectification occurs in this system because oxidized FTMA does not mix with interfacial assemblies of reduced FTMA or DTAB formed at hydrophobic electrodes. More broadly, these results show that self-assembling redox mediators, when combined with chemically functionalized electrodes, offer the basis of new principles for controlling charge transfer at electrode/solution interfaces.
RESUMEN
Adeno-associated virus (AAV) is a member of the genus Dependoparvovirus, which infects a wide range of vertebrate species. Here, we observe that, unlike most primate AAV isolates, avian AAV is transcriptionally silenced in human cells. By swapping the VP1 N terminus from primate AAVs (e.g., AAV8) onto non-mammalian isolates (e.g., avian AAV), we identify a minimal component of the AAV capsid that controls viral transcription and unlocks robust transduction in both human cells and mouse tissue. This effect is accompanied by increased AAV genome chromatin accessibility and altered histone methylation. Proximity ligation analysis reveals that host factors are selectively recruited by the VP1 N terminus of AAV8 but not avian AAV. Notably, these include AAV essential factors implicated in the nuclear factor κB pathway, chromatin condensation, and histone methylation. We postulate that the AAV capsid has evolved mechanisms to recruit host factors to its genome, allowing transcriptional activation in a species-specific manner.
Asunto(s)
Cápside , Dependovirus , Humanos , Animales , Ratones , Cápside/metabolismo , Dependovirus/metabolismo , Histonas/metabolismo , Transcripción Viral , Vectores Genéticos , Proteínas de la Cápside/genética , Proteínas de la Cápside/metabolismo , Primates , Especificidad del Huésped , Cromatina/metabolismoRESUMEN
The structure of the title salt (systematic name: oxodiphenyl-λ5-iodanylium 4-methyl-benzene-sulfonate dihydrate), C12H10IO+·C7H7O3S-·2H2O, at 150â K, has monoclinic (P21/c) symmetry. The mol-ecular structure features an angular (phenyl-iodos-yl)benzene cation, the geometry of which was hitherto undescribed in the literature: in the cation, both I-C bonds are approximately normal to the I=O bond, forming a C-I-C angle of 95.36â (4)°. The crystal structure displays O-Hâ¯O, O-Hâ¯I and O-Hâ¯S hydrogen bonding.
RESUMEN
Pulmonary arterial hypertension (PAH) is an unmet clinical need. The lack of models of human disease is a key obstacle to drug development. We present a biomimetic model of pulmonary arterial endothelial-smooth muscle cell interactions in PAH, combining natural and induced bone morphogenetic protein receptor 2 (BMPR2) dysfunction with hypoxia to induce smooth muscle activation and proliferation, which is responsive to drug treatment. BMPR2- and oxygenation-specific changes in endothelial and smooth muscle gene expression, consistent with observations made in genomic and biochemical studies of PAH, enable insights into underlying disease pathways and mechanisms of drug response. The model captures key changes in the pulmonary endothelial phenotype that are essential for the induction of SMC remodelling, including a BMPR2-SOX17-prostacyclin signalling axis and offers an easily accessible approach for researchers to study pulmonary vascular remodelling and advance drug development in PAH.
Asunto(s)
Hipertensión Pulmonar , Hipertensión Arterial Pulmonar , Factores de Transcripción SOXF , Humanos , Receptores de Proteínas Morfogenéticas Óseas de Tipo II/genética , Receptores de Proteínas Morfogenéticas Óseas de Tipo II/metabolismo , Epoprostenol/genética , Epoprostenol/metabolismo , Hipertensión Pulmonar/genética , Hipertensión Pulmonar/metabolismo , Hipertensión Arterial Pulmonar/genética , Factores de Transcripción SOXF/genética , Factores de Transcripción SOXF/metabolismoRESUMEN
Recombinant adeno-associated viral (AAV) vectors are a promising gene delivery platform, but ongoing clinical trials continue to highlight a relatively narrow therapeutic window. Effective clinical translation is confounded, at least in part, by differences in AAV biology across animal species. Here, we tackle this challenge by sequentially evolving AAV capsid libraries in mice, pigs and macaques. We discover a highly potent, cross-species compatible variant (AAV.cc47) that shows improved attributes benchmarked against AAV serotype 9 as evidenced by robust reporter and therapeutic gene expression, Cre recombination and CRISPR genome editing in normal and diseased mouse models. Enhanced transduction efficiency of AAV.cc47 vectors is further corroborated in macaques and pigs, providing a strong rationale for potential clinical translation into human gene therapies. We envision that ccAAV vectors may not only improve predictive modeling in preclinical studies, but also clinical translatability by broadening the therapeutic window of AAV based gene therapies.
Asunto(s)
Dependovirus , Edición Génica , Animales , Dependovirus/metabolismo , Terapia Genética , Vectores Genéticos/genética , Humanos , Macaca/genética , Ratones , Porcinos , Transducción GenéticaRESUMEN
BACKGROUND: Infants under 6 months (U6M) contribute a significant proportion of the burden and mortality of severe malnutrition globally. Evidence of underlying aetiology in this population is sparse, but it is known that the group includes ex-preterm and low birthweight (LBW) infants. They represent a unique population given their dependence on breastmilk or a safe, secure alternative. Nutrition agencies and health providers struggle to make programming decisions on which interventions should be provided to this group based upon the 2013 WHO Guidelines for the 'Management of Severe Acute Malnutrition in Infants and Young Children' since there are no published interventional trial data focussed on this population. Interim guidance for this group might be informed by evidence of safety and efficacy in adjacent population groups. METHODOLOGY: A narrative literature review was performed of systematic reviews, meta-analyses and randomised controlled trials of antimicrobial and micronutrient interventions (antibiotics, deworming, vitamin A, vitamin D, iron, zinc, folic acid and oral rehydration solution (ORS) for malnutrition) across the population groups of low birthweight/preterm infants, infants under 6 months, infants and children over 6 months with acute malnutrition or through supplementation to breastfeeding mothers. Outcomes of interest were safety and efficacy, in terms of mortality and morbidity. RESULTS: Ninety-four articles were identified for inclusion within this review. None of these studied interventions exclusively in severely malnourished infants U6M. 64% reported on the safety of studied interventions. Significant heterogeneity was identified in definitions of study populations, interventions provided, and outcomes studied. The evidence for efficacy and safety across population groups is reviewed and presented for the interventions listed. CONCLUSIONS: The direct evidence base for medical interventions for severely malnourished infants U6M is sparse. Our review identifies a specific need for accurate micronutrient profiling and interventional studies of micronutrients and oral fluid management of diarrhoea amongst infants U6M meeting anthropometric criteria for severe malnutrition. Indirect evidence presented in this review may help shape interim policy and programming decisions as well as the future research agenda for the management of infants U6M identified as malnourished.
RESUMEN
Gigaxonin (also known as KLHL16) is an E3 ligase adaptor protein that promotes the ubiquitination and degradation of intermediate filament (IF) proteins. Mutations in human gigaxonin cause the fatal neurodegenerative disease giant axonal neuropathy (GAN), in which IF proteins accumulate and aggregate in axons throughout the nervous system, impairing neuronal function and viability. Despite this pathophysiological significance, the upstream regulation and downstream effects of normal and aberrant gigaxonin function remain incompletely understood. Here, we report that gigaxonin is modified by
Asunto(s)
Acetilglucosamina/metabolismo , Proteínas del Citoesqueleto/metabolismo , Neuropatía Axonal Gigante/metabolismo , Proteínas de Filamentos Intermediarios/metabolismo , Antígenos de Neoplasias/metabolismo , Sitios de Unión , Línea Celular , Proteínas del Citoesqueleto/genética , Epigénesis Genética , Terapia Genética , Neuropatía Axonal Gigante/etiología , Neuropatía Axonal Gigante/genética , Neuropatía Axonal Gigante/terapia , Glicosilación , Histona Acetiltransferasas/metabolismo , Humanos , Hialuronoglucosaminidasa/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Modelos Biológicos , Estado Nutricional , Complejo de la Endopetidasa Proteasomal/metabolismo , Unión Proteica , Proteostasis , Serina/metabolismo , Treonina/metabolismo , Ubiquitina/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , UbiquitinaciónRESUMEN
INTRODUCTION: Isolated limb infusion (ILI) is a minimally-invasive procedure for delivering high-dose regional chemotherapy to treat melanoma in-transit metastases confined to a limb. The aim of this international multi-centre study was to identify predictive factors for toxicity and response. METHODS: Data of 687 patients who underwent a first ILI for melanoma in-transit metastases confined to the limb between 1992 and 2018 were collected at five Australian and four US tertiary referral centres. RESULTS: After ILI, predictive factors for increased limb toxicity (Wieberdink grade III/IV limb toxicity, n = 192, 27.9%) were: female gender, younger age, procedures performed before 2005, lower limb procedures, higher melphalan dose, longer drug circulation and ischemia times, and increased tissue hypoxia. No patient experienced grade V toxicity (necessitating amputation). A complete response (n = 199, 28.9%) was associated with a lower stage of disease, lower burden of disease (BOD) and thinner Breslow thickness of the primary melanoma. Additionally, an overall response (combined complete and partial response, n = 441, 64.1%) was associated with female gender, Australian centres, procedures performed before 2005, lower limb procedures and lower actinomycin-D doses. On multivariate analysis, higher melphalan dose remained a predictive factor for toxicity, while lower stage of disease and lower BOD remained predictive factors for overall response. CONCLUSION: ILI is safe and effective to treat melanoma in-transit metastases. Predictive factors for toxicity and response identified in this study will allow improved patient selection and optimization of intra-operative parameters to increase response rates, while keeping toxicity low.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Quimioterapia del Cáncer por Perfusión Regional/efectos adversos , Melanoma/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Factores de Edad , Anciano , Anciano de 80 o más Años , Amputación Quirúrgica , Australia , Creatina Quinasa/metabolismo , Dactinomicina/administración & dosificación , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Isquemia/etiología , Isquemia/metabolismo , Extremidad Inferior , Masculino , Melanoma/patología , Melfalán/administración & dosificación , Persona de Mediana Edad , Metástasis de la Neoplasia , Factores Sexuales , Neoplasias Cutáneas/patología , Factores de Tiempo , Torniquetes , Estados Unidos , Extremidad SuperiorRESUMEN
The optical stretcher is a dual-beam trap capable of stretching individual cells. Previous studies have used either ray- or wave-optical models to compute the optical pressure on the surface of a spherical cell. We have extended the ray-optics model to account for focusing by the spherical interface and the effects of multiple internal reflections. Simulation results for red-blood cells (RBCs) show that internal reflections can lead to significant perturbation of the deformation, leading to a systematic error in the determination of cellular elasticity. Calibration studies show excellent agreement between the predicted and measured escape force, and RBC stiffness measurements are consistent with literature values. Measurements of the elasticity of murine osteogenic cells reveal that these cells are approximately 5.4 times stiffer than RBCs.
Asunto(s)
Módulo de Elasticidad/fisiología , Eritrocitos/citología , Eritrocitos/fisiología , Pruebas de Dureza/métodos , Modelos Cardiovasculares , Nefelometría y Turbidimetría/métodos , Pinzas Ópticas , Animales , Simulación por Computador , Dureza/fisiología , Humanos , Luz , Dispersión de RadiaciónRESUMEN
Our laboratory recently reported gut pathology following incidental ingestion of titanium dioxide nanoparticles (TiO(2) NPs) during aqueous exposures in trout, but there are almost no data on dietary exposure to TiO(2) NPs in fish. The aim of this experiment was to observe the sub-lethal effects of dietary exposure to TiO(2) NPs in juvenile rainbow trout (Oncorhynchus mykiss). Stock solutions of dispersed TiO(2) NPs were prepared by sonication without the use of solvents and applied to a commercial trout diet. Fish were exposed in triplicate to either, control (no added TiO(2)), 10, or 100 mg kg(-1) TiO(2) NPs diets for 8 weeks followed by a 2 week recovery period where all fish were fed the control diet. TiO(2) NPs had no impact on growth or nutritional performance, and no major disturbances were observed in red or white blood cell counts, haematocrits, whole blood haemoglobin, or plasma Na(+). Ti accumulation occurred in the gill, gut, liver, brain and spleen during dietary TiO(2) exposure. Notably, some of these organs, especially the brain, did not clear Ti after exposure. The brain also showed disturbances to Cu and Zn levels (statistically significant at weeks 4 and 6; ANOVA or Kruskal-Wallis, P < 0.05) and a 50% inhibition of Na(+)K(+)-ATPase activity during TiO(2) NP exposure. Na(+)K(+)-ATPase activity was unaffected in the gills and intestine. Total glutathione in the gills, intestine, liver and brain were not affected by dietary TiO(2) NPs, but thiobarbituric acid reactive substances (TBARS) showed up to 50% decreases in the gill and intestine. We conclude that TiO(2) NPs behave like other toxic dietary metals where growth rate and haematology can be protected during sub-lethal exposures, but in the case of TiO(2) NPs this may be at the expense of critical organs such as the brain and the spleen.
Asunto(s)
Encéfalo/efectos de los fármacos , Nanopartículas del Metal/toxicidad , Oncorhynchus mykiss/fisiología , Titanio/toxicidad , Contaminantes Químicos del Agua/toxicidad , Alimentación Animal , Animales , Encéfalo/metabolismo , Cobre/análisis , Branquias/efectos de los fármacos , Branquias/metabolismo , Glutatión/metabolismo , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Nanopartículas del Metal/administración & dosificación , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Titanio/administración & dosificación , Titanio/farmacocinética , Pruebas de Toxicidad , Contaminantes Químicos del Agua/administración & dosificación , Privación de Tratamiento , Zinc/análisisRESUMEN
Factors associated with the intravaginal release of an anti-HIV agent from an alginate complex were considered. Among these is citrate associated with prostatic fluid. This study demonstrates that citrate, at a physiologically appropriate concentration, facilitates the release of an anti-HIV polymer from a calcium alginate complex. The release of the agent can be modified by the concentration of the calcium and alginate in the complex. These results suggest that seminal and prostatic fluid can be considered in the design of an intravaginal system for HIV chemoprophylaxis.